Fetroja

Osaka, Japan – August 28, 2026 Shionogi & Co., Ltd. announced that the Biomedical Advanced Research and Development Authority...

FLORHAM PARK, N.J., July 16, 2026 Shionogi Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted...

OSAKA, Japan, April 8, 2026 Shionogi & Co., Ltd. presented new real-world clinical data for Fetroja®/Fetcroja® (cefiderocol) at ESCMID...